SEC Form 4 · accession 0001235802-17-000161
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin L Mensink
Officer — Vice President, Marketing
Period of report
Oct 20, 2017
Accepted (ET)
Oct 24, 2017 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Oct 20, 2017 | M | 2,500 | $1.24 | A | 10,000 | D | |
| Common Stock, $0.001 par valueF1 | Oct 20, 2017 | S | 2,500 | $19.00 | D | 7,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $1.24 | Oct 20, 2017 | M | 2,500 | D | — | Apr 8, 2023 | Common Stock | 2,500 | 58,900 | D |
Explanation of responses
- F1Includes 7,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan.
- F2These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F3This option vested as to twenty-five percent (25%) of the shares underlying the option on April 8, 2014, with the remaining shares vesting in 36 substantially equal monthly installments on each monthly anniversary of the grant date thereafter, subject to continued employment or service with the Issuer through each applicable vesting date.